eClinical Solutions A Technology that Help Accelerate the Clinical Development Process
eClinical solutions help improve the clinical process
through data management and analysis. It allows users to integrate, manage,
analyze, and standardize clinical and operational data with integrated advanced
visualization and analytical capabilities. eClinical S also manage clinical
technologies and expertise to facilitate the acceleration of the clinical
development. Moreover, eClinical sol are used to manage clinical trials and
clinical research, as well as help maintain, track, manage, and record data/information.
Moreover, eClinical sol help researchers to
efficiently organize, standardize, and manage their clinical research data and
metadata during their research lifecycle. eClinical sol helps life sciences
organizations around the world accelerate clinical development initiatives with
expert data services and an elluminate Clinical Data Cloud, the foundation of
digital trials. eClinical software allows users to analyze, manage, integrate,
and standardize all their clinical and operational data with the help of
integrated visualization and analytical capabilities.
The global eClinical
Solutions Market was valued at US$ 3.5 billion in 2017 and is expected to
witness a robust CAGR of 11.2% over the forecast period (2018 – 2026).
Moreover, some eClinical solutions help users to
comply with government regulations, patient management, budgeting, investigator
management, and adverse event reporting system among others. Originally,
eClinical was used to refer to any involved technology, however, eClinical is a
term used within the biopharma industry to refer to trial automation
technology. They help transform the way clinical data integration, aggregation,
and analytics. It provides end-to-end data management services and cloud-based
products for clinical data optimization.
Therefore, the use of eClinical sol is increasing
around the world, especially in the drug development process. For example, in January
2020, ERT announced an ERT record: 75% of compounds approved by U.S. FDA (Food
and Drug Administration) in 2019 were developed using one or more of ERT’s
eClinical sol during a drug development process. Moreover, ERT delivers
innovative solutions that help biopharma companies meet global regulators’
strict guidelines for demonstrating the safety and efficacy of new medical
compounds.
Comments
Post a Comment